...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: And we wait.....
7
Jan 23, 2018 11:04AM
6
Jan 23, 2018 02:26PM
5
Jan 23, 2018 02:40PM

Jan 25, 2018 04:52PM
3
Jan 26, 2018 12:11PM
4
Jan 27, 2018 08:00AM
5
Jan 28, 2018 12:04PM
7
Jan 28, 2018 08:17PM
2
Jan 29, 2018 11:16AM

hummmmmmmm,,,they sit beside my B549794 Bre-X shares for now,,,,,I assume cuz they mirror eachother,,, :o) ,,,,but nice try there big fella,,,,its the time factor which I assume is partially based or more wholly on 208 being the draft horse for the ZENs!!!And we all know Zen is a form of Buddhism with lots of meditation involved,,,and that must mean we need to have patience with lots of idle time on our hands.

I again assume ZEN Cap and ZEN Epi will be in the cross hairs by our big insiders if 208 makes its' mark,,,,and of course if ZEN-3694 hits in oncology...........just a brain fart which is still just an opinion,,,which again each of have one!!,,,,I am certainly a poor investor,,,,,may have to try my hand at a different trade!!!,,, Maybe Ill run some international conferences!!!,,  :o)

1
Jan 29, 2018 07:48PM
3
Jan 30, 2018 07:41AM

Jan 30, 2018 04:56PM
5
Jan 31, 2018 05:26PM
Share
New Message
Please login to post a reply